| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.594 | 0.004 | 0.594 | Dopamine D4 antagonist | |||
| 0.573 | 0.011 | 0.573 | GABA C receptor rho-3 antagonist | |||
| 0.527 | 0.006 | 0.527 | 5 Hydroxytryptamine antagonist | |||
| 0.521 | 0.03 | 0.521 | Aldehyde oxidase inhibitor | |||
| 0.482 | 0.007 | 0.482 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.474 | 0.006 | 0.474 | Dopamine antagonist | |||
| 0.46 | 0.005 | 0.46 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.463 | 0.044 | 0.463 | Histamine release inhibitor | 0.358 0.096 CID_154699771 | ||
| 0.422 | 0.004 | 0.422 | Dopamine D1 antagonist | |||
| 0.451 | 0.036 | 0.451 | 5 Hydroxytryptamine release stimulant | |||
| 0.412 | 0.003 | 0.412 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.394 | 0.005 | 0.394 | Histamine H1 receptor antagonist | |||
| 0.411 | 0.027 | 0.411 | Hypoxia-inducible factor 1 alpha inhibitor | 0.292 0.07 CID_154699771 | ||
| 0.389 | 0.007 | 0.389 | Dopamine D2 antagonist | |||
| 0.361 | 0.002 | 0.361 | 5 Hydroxytryptamine 3 agonist | |||
| 0.354 | 0.006 | 0.354 | Toll-Like receptor 9 antagonist | |||
| 0.338 | 0.005 | 0.338 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.32 | 0.005 | 0.32 | Dopamine D3 antagonist | |||
| 0.312 | 0.003 | 0.312 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.316 | 0.008 | 0.316 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.345 | 0.039 | 0.345 | HERG channel blocker | |||
| 0.313 | 0.014 | 0.313 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.306 | 0.009 | 0.306 | Alpha 2b adrenoreceptor antagonist | |||
| 0.34 | 0.05 | 0.34 | Aryl hydrocarbon receptor agonist | |||
| 0.311 | 0.023 | 0.311 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.378 | 0.093 | 0.378 | 5 Hydroxytryptamine release inhibitor | |||
| 0.277 | 0.004 | 0.277 | 5 Hydroxytryptamine 3A agonist | |||
| 0.272 | 0.004 | 0.272 | Acetylcholine M4 receptor antagonist | |||
| 0.275 | 0.008 | 0.275 | Alpha 2a adrenoreceptor antagonist | |||
| 0.279 | 0.017 | 0.279 | Alpha adrenoreceptor antagonist | |||
| 0.269 | 0.012 | 0.269 | Antihistaminic | |||
| 0.303 | 0.049 | 0.303 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.257 | 0.005 | 0.257 | Dopamine D4 agonist | |||
| 0.293 | 0.045 | 0.293 | Psychostimulant | 0.206 0.077 CID_154699771 | ||
| 0.258 | 0.013 | 0.258 | Histamine antagonist | |||
| 0.245 | 0.008 | 0.245 | Protein kinase C zeta inhibitor | |||
| 0.254 | 0.02 | 0.254 | NADPH oxidase inhibitor | |||
| 0.239 | 0.012 | 0.239 | Alpha 2 adrenoreceptor antagonist | |||
| 0.276 | 0.055 | 0.276 | Potassium channel blocker | |||
| 0.223 | 0.003 | 0.223 | Histamine H4 receptor antagonist | |||
| 0.264 | 0.045 | 0.264 | ErbB-1 antagonist | |||
| 0.354 | 0.146 | 0.354 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.237 | 0.029 | 0.237 | Acetylcholine M1 receptor antagonist | 0.129 0.097 CID_154699771 | ||
| 0.224 | 0.018 | 0.224 | Alpha 1 adrenoreceptor antagonist | |||
| 0.205 | 0.002 | 0.205 | Histamine H4 receptor agonist | |||
| 0.218 | 0.015 | 0.218 | Alpha 2c adrenoreceptor antagonist | |||
| 0.199 | 0.004 | 0.199 | Histamine agonist | |||
| 0.21 | 0.016 | 0.21 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.203 | 0.012 | 0.203 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.312 | 0.125 | 0.312 | MAP kinase kinase 6 inhibitor | |||
| 0.24 | 0.056 | 0.253 | RNA-directed DNA polymerase inhibitor | 0.253 0.047 CID_154699771 | CID_154699771 | |
| 0.187 | 0.007 | 0.187 | GABA receptor antagonist | |||
| 0.222 | 0.045 | 0.222 | Amyloid beta precursor protein antagonist | |||
| 0.235 | 0.061 | 0.235 | MAP kinase kinase 2 inhibitor | |||
| 0.203 | 0.03 | 0.203 | Toll-Like receptor antagonist | |||
| 0.174 | 0.004 | 0.174 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.205 | 0.035 | 0.205 | Ribosomal protein S6 kinase inhibitor | |||
| 0.186 | 0.018 | 0.186 | Alpha 1a adrenoreceptor antagonist | |||
| 0.172 | 0.005 | 0.172 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.248 | 0.083 | 0.248 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.178 | 0.017 | 0.178 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.204 | 0.056 | 0.204 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.283 | 0.142 | 0.283 | 15-Lipoxygenase inhibitor | |||
| 0.181 | 0.042 | 0.181 | GABA C receptor rho-2 antagonist | |||
| 0.157 | 0.022 | 0.157 | Multidrug resistance-associated protein 1 inhibitor | 0.104 0.072 CID_154699771 | ||
| 0.144 | 0.01 | 0.144 | Protein kinase B alpha inhibitor | |||
| 0.156 | 0.024 | 0.156 | Protein kinase C mu inhibitor | 0.081 0.079 CID_154699771 | ||
| 0.206 | 0.075 | 0.36 | DNA methylase inhibitor | 0.36 0.015 CID_154699771 | CID_154699771 | |
| 0.151 | 0.022 | 0.151 | Alpha 1b adrenoreceptor antagonist | |||
| 0.132 | 0.006 | 0.132 | 5 Hydroxytryptamine 2 agonist | |||
| 0.201 | 0.075 | 0.201 | Neurotrophic factor enhancer | |||
| 0.198 | 0.072 | 0.198 | I kappa B kinase epsilon inhibitor | |||
| 0.136 | 0.011 | 0.136 | Benzodiazepine agonist | |||
| 0.139 | 0.015 | 0.139 | mTOR complex 1 inhibitor | |||
| 0.135 | 0.012 | 0.135 | mTOR complex 2 inhibitor | |||
| 0.129 | 0.011 | 0.129 | Acetylcholine M5 receptor antagonist | |||
| 0.19 | 0.074 | 0.334 | DNA methyltransferase I inhibitor | 0.334 0.017 CID_154699771 | CID_154699771 | |
| 0.234 | 0.121 | 0.234 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.122 | 0.014 | 0.122 | Protein kinase B beta inhibitor | |||
| 0.14 | 0.032 | 0.14 | Transcription factor STAT6 inhibitor | |||
| 0.131 | 0.025 | 0.131 | 5 Hydroxytryptamine agonist | |||
| 0.22 | 0.115 | 0.22 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.112 | 0.008 | 0.112 | Dopamine D5 antagonist | |||
| 0.198 | 0.095 | 0.258 | Cyclic AMP phosphodiesterase inhibitor | 0.258 0.06 CID_154699771 | CID_154699771 | |
| 0.124 | 0.021 | 0.124 | Alpha adrenoreceptor agonist | |||
| 0.16 | 0.059 | 0.16 | Activin receptor-like kinase 2 inhibitor | |||
| 0.108 | 0.01 | 0.108 | Aryl hydrocarbon receptor antagonist | |||
| 0.113 | 0.019 | 0.113 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.135 | 0.04 | 0.135 | Antiadrenergic | |||
| 0.142 | 0.049 | 0.142 | Acetylcholine muscarinic antagonist | 0.107 0.082 CID_154699771 | ||
| 0.132 | 0.04 | 0.132 | Adrenaline antagonist | |||
| 0.126 | 0.039 | 0.126 | Acetylcholine release stimulant | |||
| 0.145 | 0.058 | 0.148 | Heat shock protein 70 antagonist | 0.148 0.051 CID_154699771 | CID_154699771 | |
| 0.135 | 0.048 | 0.135 | Cystathionine beta-synthase inhibitor | |||
| 0.101 | 0.014 | 0.101 | 5 Hydroxytryptamine 2A agonist | |||
| 0.195 | 0.109 | 0.195 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.101 | 0.016 | 0.101 | GABA A receptor antagonist | |||
| 0.13 | 0.047 | 0.13 | TRPA1 agonist | |||
| 0.119 | 0.037 | 0.119 | Acetylcholine agonist | |||
| 0.125 | 0.043 | 0.125 | Mediator release inhibitor | |||
| 0.098 | 0.017 | 0.098 | Alpha 1 adrenoreceptor agonist | |||
| 0.101 | 0.022 | 0.101 | Transforming growth factor beta 3 antagonist | |||
| 0.211 | 0.132 | 0.211 | Gastrin inhibitor | |||
| 0.117 | 0.043 | 0.117 | Potassium channel (Ca-activated) activator | |||
| 0.1 | 0.026 | 0.1 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.107 | 0.034 | 0.107 | Glutamate release inhibitor | |||
| 0.083 | 0.011 | 0.083 | 5 Hydroxytryptamine 7 agonist | |||
| 0.107 | 0.037 | 0.107 | ALK inhibitor | |||
| 0.155 | 0.089 | 0.155 | Antipruritic | |||
| 0.28 | 0.216 | 0.285 | Caspase 9 stimulant | 0.285 0.211 CID_154699771 | CID_154699771 | |
| 0.11 | 0.046 | 0.11 | Phosphodiesterase 7B inhibitor | |||
| 0.068 | 0.005 | 0.068 | Histamine H1 receptor agonist | |||
| 0.083 | 0.021 | 0.083 | Acetylcholine muscarinic agonist | |||
| 0.1 | 0.04 | 0.1 | Bromodomain-containing protein 2 inhibitor | |||
| 0.094 | 0.035 | 0.094 | Protein kinase B gamma inhibitor | |||
| 0.081 | 0.023 | 0.081 | Protease activated receptor antagonist | |||
| 0.075 | 0.017 | 0.075 | Acetylcholine M1 receptor agonist | |||
| 0.09 | 0.033 | 0.09 | Cyclin B3 inhibitor | |||
| 0.061 | 0.009 | 0.061 | Nerve growth factor antagonist | |||
| 0.086 | 0.034 | 0.086 | Dopamine agonist | |||
| 0.146 | 0.095 | 0.146 | Interleukin 6 antagonist | 0.141 0.103 CID_154699771 | ||
| 0.095 | 0.044 | 0.095 | Platelet growth factor antagonist | |||
| 0.122 | 0.072 | 0.122 | Cholinergic antagonist | |||
| 0.12 | 0.071 | 0.12 | Acetylcholine antagonist | |||
| 0.077 | 0.029 | 0.077 | Adrenaline uptake inhibitor | |||
| 0.078 | 0.031 | 0.078 | Alpha 1d adrenoreceptor antagonist | |||
| 0.06 | 0.012 | 0.06 | GABA B receptor antagonist | |||
| 0.075 | 0.028 | 0.075 | Dopamine uptake inhibitor | |||
| 0.079 | 0.032 | 0.079 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.072 | 0.026 | 0.072 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.059 | 0.014 | 0.059 | Benzodiazepine antagonist | |||
| 0.054 | 0.01 | 0.054 | Potassium channel small-conductance Ca-activated activator | |||
| 0.064 | 0.02 | 0.064 | Glutamate (mGluR group I) agonist | |||
| 0.074 | 0.033 | 0.074 | Acetylcholine M2 receptor antagonist | |||
| 0.088 | 0.047 | 0.088 | D-Ala-D-Ala ligase inhibitor | |||
| 0.071 | 0.031 | 0.071 | Alpha 2 adrenoreceptor agonist | |||
| 0.111 | 0.071 | 0.111 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.066 | 0.027 | 0.066 | Phosphatidylinositol 3-kinase alpha inhibitor | |||
| 0.132 | 0.094 | 0.132 | Pregnane X receptor agonist | |||
| 0.066 | 0.029 | 0.066 | Fatty acid synthase inhibitor | |||
| 0.068 | 0.031 | 0.068 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.072 | 0.034 | 0.072 | MDM2 inhibitor | |||
| 0.051 | 0.014 | 0.051 | Vascular adhesion protein 1 inhibitor | |||
| 0.07 | 0.033 | 0.07 | Phosphatidylinositol kinase inhibitor | |||
| 0.068 | 0.032 | 0.068 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.049 | 0.014 | 0.049 | 5 Hydroxytryptamine 2B agonist | |||
| 0.06 | 0.024 | 0.06 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.078 | 0.043 | 0.078 | MAP3K7 inhibitor | |||
| 0.118 | 0.086 | 0.118 | Nav1.2 sodium channel blocker | |||
| 0.045 | 0.014 | 0.045 | CF transmembrane conductance regulator antagonist | |||
| 0.077 | 0.047 | 0.077 | Vanilloid 4 agonist | |||
| 0.054 | 0.025 | 0.054 | 5 Hydroxytryptamine 2C agonist | |||
| 0.152 | 0.125 | 0.152 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.062 | 0.036 | 0.062 | EphB4 antagonist | |||
| 0.039 | 0.013 | 0.039 | Protein kinase (CK2) beta inhibitor | |||
| 0.12 | 0.095 | 0.12 | Nav1.6 sodium channel blocker | |||
| 0.039 | 0.014 | 0.039 | Adenosine uptake inhibitor | |||
| 0.069 | 0.045 | 0.069 | Acetylcholine M5 receptor agonist | |||
| 0.046 | 0.022 | 0.046 | Alpha 1L adrenoreceptor agonist | |||
| 0.092 | 0.07 | 0.092 | Sphingomyelinase inhibitor | |||
| 0.077 | 0.056 | 0.077 | MAP kinase 7 inhibitor | |||
| 0.124 | 0.103 | 0.124 | Cholinergic | |||
| 0.115 | 0.095 | 0.115 | Cytokine production inhibitor | |||
| 0.091 | 0.072 | 0.091 | Electrolyte absorption antagonist | |||
| 0.113 | 0.094 | 0.113 | Sodium channel blocker | |||
| 0.075 | 0.056 | 0.075 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.03 | 0.013 | 0.03 | 5 Hydroxytryptamine 1F agonist | |||
| 0.059 | 0.043 | 0.059 | Phosphodiesterase 1B inhibitor | |||
| 0.111 | 0.096 | 0.111 | Antibacterial (Helicobacter pylori) | |||
| 0.049 | 0.035 | 0.049 | Potassium channel (Inward rectifier) blocker | |||
| 0.059 | 0.045 | 0.059 | TRPA1 antagonist | |||
| 0.024 | 0.01 | 0.024 | Imidazoline I1 receptor antagonist | |||
| 0.045 | 0.033 | 0.045 | 5 Hydroxytryptamine 1A agonist | |||
| 0.182 | 0.17 | 0.182 | Prostaglandin dehydrogenase inhibitor | |||
| 0.066 | 0.055 | 0.066 | Amidase inhibitor | |||
| 0.045 | 0.033 | 0.045 | Glutamate (mGluR5) agonist | |||
| 0.13 | 0.119 | 0.13 | Ca2+-transporting ATPase inhibitor | |||
| 0.04 | 0.029 | 0.04 | Acid-sensing ion channel blocker | |||
| 0.075 | 0.065 | 0.075 | Acetylcholine M3 receptor agonist | |||
| 0.136 | 0.127 | 0.136 | ATPase inhibitor | |||
| 0.057 | 0.048 | 0.057 | Phosphodiesterase 1A inhibitor | |||
| 0.065 | 0.058 | 0.065 | Protein kinase C beta inhibitor | |||
| 0.091 | 0.083 | 0.091 | Hedgehog signaling inhibitor | |||
| 0.026 | 0.02 | 0.026 | Myristoyl transferase inhibitor | |||
| 0.077 | 0.071 | 0.077 | Insulin growth factor antagonist | |||
| 0.045 | 0.04 | 0.045 | Phosphatidylinositol 3-kinase beta inhibitor | |||
| 0.075 | 0.069 | 0.075 | Insulin like growth factor 1 antagonist | |||
| 0.088 | 0.083 | 0.088 | Phosphodiesterase 6D inhibitor | |||
| 0.027 | 0.023 | 0.027 | 5 Hydroxytryptamine 6 agonist | |||
| 0.075 | 0.071 | 0.075 | Phosphodiesterase 11A inhibitor | |||
| 0.075 | 0.071 | 0.075 | Phosphodiesterase XI inhibitor | |||
| 0.032 | 0.028 | 0.032 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.045 | 0.041 | 0.045 | 5 Hydroxytryptamine 1 agonist | |||
| 0.067 | 0.063 | 0.078 | Adenosine A3 receptor antagonist | 0.078 0.046 CID_154699771 | CID_154699771 | |
| 0.069 | 0.065 | 0.069 | Phosphodiesterase VI inhibitor | |||
| 0.095 | 0.091 | 0.095 | Topoisomerase II inhibitor | |||
| 0.041 | 0.038 | 0.041 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.095 | 0.092 | 0.095 | CDC-like kinase 3 inhibitor | |||
| 0.048 | 0.046 | 0.048 | Nicotinic alpha7 receptor agonist | |||
| 0.127 | 0.125 | 0.127 | Dual specificity phosphatase inhibitor | |||
| 0.12 | 0.118 | 0.12 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.093 | 0.091 | 0.093 | Protein kinase C gamma inhibitor | |||
| 0.086 | 0.084 | 0.086 | Insulin receptor antagonist | |||
| 0.049 | 0.047 | 0.049 | Phosphatidylinositol 3-kinase gamma inhibitor | |||
| 0.044 | 0.042 | 0.044 | Phosphodiesterase 6C inhibitor | |||
| 0.075 | 0.074 | 0.075 | Caspase 7 inhibitor | |||
| 0.106 | 0.107 | 0.13 | DNA repair enzyme inhibitor | 0.13 0.055 CID_154699771 | CID_154699771 | |
| 0.086 | 0.096 | 0.095 | Beta glucuronidase inhibitor | 0.095 0.078 CID_154699771 | CID_154699771 | |
| 0.014 | 0.027 | 0.024 | Adenosine kinase inhibitor | 0.024 0.013 CID_154699771 | CID_154699771 | |
| 0.182 | 0.199 | 0.318 | Vasodilator, coronary | 0.318 0.074 CID_154699771 | CID_154699771 | |
| 0.037 | 0.066 | 0.068 | Adenosine A1 receptor antagonist | 0.068 0.034 CID_154699771 | CID_154699771 | |
| 0.041 | 0.072 | 0.064 | Heparanase inhibitor | 0.064 0.017 CID_154699771 | CID_154699771 | |
| 0.138 | 0.177 | 0.319 | Spasmolytic | 0.319 0.063 CID_154699771 | CID_154699771 | |
| 0.024 | 0.066 | 0.077 | Purinergic P2Y antagonist | 0.077 0.014 CID_154699771 | CID_154699771 | |
| 0.139 | 0.182 | 0.179 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.179 0.094 CID_154699771 | CID_154699771 | |
| 0.148 | 0.207 | 0.254 | DNA synthesis inhibitor | 0.254 0.064 CID_154699771 | CID_154699771 | |
| 0.09 | 0.149 | 0.26 | Cytidine deaminase inhibitor | 0.26 0.027 CID_154699771 | CID_154699771 | |
| 0.095 | 0.169 | 0.164 | Hexokinase inhibitor | 0.164 0.063 CID_154699771 | CID_154699771 | |
| 0.155 | 0.263 | 0.275 | Apoptosis antagonist | 0.275 0.104 CID_154699771 | CID_154699771 | |
| 0.032 | 0.167 | 0.06 | Purinergic P2X1 antagonist | 0.06 0.043 CID_154699771 | CID_154699771 | |
| 0.039 | 0.176 | 0.186 | Topoisomerase I inhibitor | 0.186 0.03 CID_154699771 | CID_154699771 | |
| 0.084 | 0.223 | 0.162 | Insulin secretagoues | 0.162 0.063 CID_154699771 | CID_154699771 | |
| 0.049 | 0.207 | 0.108 | NADH dehydrogenase inhibitor | 0.108 0.036 CID_154699771 | CID_154699771 | |
| 0.126 | 0.289 | 0.256 | Immunomodulator | 0.256 0.11 CID_154699771 | CID_154699771 | |
| 0.185 | 0.356 | 0.295 | Antiinflammatory | 0.295 0.22 CID_154699771 | CID_154699771 | |
| 0.161 | 0.337 | 0.259 | Apoptosis agonist | 0.259 0.205 CID_154699771 | CID_154699771 | |
| 0.04 | 0.236 | 0.095 | Uric acid excretion stimulant | 0.095 0.058 CID_154699771 | CID_154699771 | |
| 0.115 | 0.314 | 0.286 | Antithrombotic | 0.286 0.098 CID_154699771 | CID_154699771 | |
| 0.044 | 0.244 | 0.099 | AMP-activated protein kinase stimulant | 0.099 0.071 CID_154699771 | CID_154699771 | |
| 0.014 | 0.222 | 0.031 | Purinergic P2Y2 antagonist | 0.031 0.027 CID_154699771 | CID_154699771 | |
| 0.006 | 0.226 | 0.018 | Adenosine A3 receptor agonist | 0.018 0.011 CID_154699771 | CID_154699771 | |
| 0.058 | 0.282 | 0.149 | Cell wall synthesis inhibitor | 0.149 0.067 CID_154699771 | CID_154699771 | |
| 0.067 | 0.296 | 0.225 | Platelet adhesion inhibitor | 0.225 0.059 CID_154699771 | CID_154699771 | |
| 0.091 | 0.419 | 0.45 | Antibacterial | 0.45 0.057 CID_154699771 | CID_154699771 | |
| 0.048 | 0.385 | 0.193 | Free radical scavenger | 0.193 0.103 CID_154699771 | CID_154699771 | |
| 0.048 | 0.428 | 0.203 | Antioxidant | 0.203 0.112 CID_154699771 | CID_154699771 | |
| 0.043 | 0.439 | 0.229 | Vasodilator | 0.229 0.083 CID_154699771 | CID_154699771 | |
| 0.005 | 0.429 | 0.015 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.015 0.01 CID_154699771 | CID_154699771 | |
| 0.047 | 0.472 | 0.195 | Hepatoprotectant | 0.195 0.068 CID_154699771 | CID_154699771 | |
| 0.003 | 0.479 | 0.023 | Purinergic P2X agonist | 0.023 0.022 CID_154699771 | CID_154699771 | |
| 0.004 | 0.501 | 0.031 | Adenosine A1 receptor agonist | 0.031 0.011 CID_154699771 | CID_154699771 | |
| 0.014 | 0.547 | 0.092 | Aminoacyl-tRNA synthetase inhibitor | 0.092 0.056 CID_154699771 | CID_154699771 | |
| 0.044 | 0.588 | 0.196 | Hypoglycemic | 0.196 0.116 CID_154699771 | CID_154699771 | |
| 0.02 | 0.569 | 0.055 | Adenine nucleotide translocase inhibitor | 0.055 0.039 CID_154699771 | CID_154699771 | |
| 0.004 | 0.622 | 0.013 | Adenosine A2b receptor agonist | 0.013 0.012 CID_154699771 | CID_154699771 | |
| 0.018 | 0.752 | 0.141 | DNA polymerase I inhibitor | 0.141 0.054 CID_154699771 | CID_154699771 | |
| 0.019 | 0.766 | 0.205 | Immunosuppressant | 0.205 0.192 CID_154699771 | CID_154699771 | |
| 0.011 | 0.782 | 0.251 | Angiogenesis stimulant | 0.251 0.069 CID_154699771 | CID_154699771 | |
| 0.056 | 0.849 | 0.299 | Peptidyltransferase inhibitor | 0.299 0.025 CID_154699771 | CID_154699771 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |